ReviewCurrent hematologic malignancy reports2018
Emerging EZH2 Inhibitors and Their Application in Lymphoma.
Jennifer K Lue et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
54 papers cite it
this paperpooled itcites it
ReviewCurrent hematologic malignancy reports2018
Jennifer K Lue et al.PubMed ↗Publisher ↗
No numbers read from the abstract.